Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Web – sheet or filament bases; compositions of bandages; or...
Patent
1998-07-07
2000-08-15
Webman, Edward J.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Web, sheet or filament bases; compositions of bandages; or...
424493, 424497, A61P 2536, A61M 3700
Patent
active
061032581
ABSTRACT:
Methods whereby a kappa-preferring opioid blocking agent is used for optimizing dopamine homeostasis during administration of opioid analgesics and for preventing mortal respiratory depression due to drug overdose.
REFERENCES:
patent: 4626539 (1986-12-01), Aungst et al.
patent: 5149538 (1992-09-01), Granger et al.
patent: 5580876 (1996-12-01), Crain et al.
patent: 5587381 (1996-12-01), Sinclair
patent: 5767125 (1998-06-01), Crain et al.
patent: 5783583 (1998-07-01), Simon
patent: 5789411 (1998-08-01), Gooberman et al.
patent: 5811451 (1998-09-01), Minoia et al.
Text--Opioid Peptides in Substance Abuse by Jozsef I. Szekely. CRC Press, Inc., p. 160 (1994).
Article--Spanagel et al.--"Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway" Proc. Natl. Acad. Sci. USA vol. 89. p. 2046. Mar. 1992.
Article--Pan et al. "Cellular mechanism for anti-analgesic action of agonists of the k-opioid receptor" Nature vol. 389/25 Sep., pp. 382-385 (1997).
Article--Kreeks et al. "Orally Administered opioid antagonists reverse both mu and kappa opioid agonists delay of gastrointestinal transit in the guinea pig"Life Sciences, vol. 56. No. 14. pp. 1187-1192. 1995.
Article--Arts et al. "Inhibition of the Antianalgesic Action of Dynorphin A in Mice by Cholera Toxin" Pharacology Biochemistry and Behavior, vol. 46. pp. 623-629. 1993.
Article--Bakashi et al. "Dynorphin A-(1-17) Induces Alterations in Free Fatty Acids, Excitatory Amino Acids, and Motor Function Through An Opiate-Receptor-Mediated Mechanism" The Journal of Neuroscience, Dec. 1990. 10(12): 3793-3800.
Article--Behrmann et al. "A Comparison of YM-14673. U-50488H, and Nalmefene after Spinal Cord Injury in the Rat" Experimental Neurology 119. 258-267 (1993).
Article--Ohnishi et al. "Aquaretic Effect of the Stable Dynorphin-A analog E2078 in the Human" The Journal of Pharmacology and Experimental Therapeutics vol. 270. No. 1. Mar. 19, 1994.
Moore Steven J.
Webman Edward J.
LandOfFree
Salts and bases of the 17-(Cyclopropylmethyl)-4,5 alpha-epoxy-6- does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Salts and bases of the 17-(Cyclopropylmethyl)-4,5 alpha-epoxy-6-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Salts and bases of the 17-(Cyclopropylmethyl)-4,5 alpha-epoxy-6- will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2003803